<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title40.html">
                                    Title 40
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/40CFR721.html">Part 721
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 721.2577  Certain copper complexes of (substituted sulfonaphthyl
                            </h3>
                            <p class="depth1"><em>(a)</em> Chemical substance and significant new uses subject to reporting. (1) The chemical substances identified as cuprate(3-), [3-[2-[5-(hydroxy-.kappa.O)-4-[2-[1-(hydroxy-.kappa.O)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-.kappa.N1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, hydrogen, compd. with 2,2'-iminobis[ethanol] (1:3:3) (PMN P-00-0364; CAS No. 1078726-27-8) and cuprate(3-), [3-[2-[5-(hydroxy-.kappa.O)-4-[2-[1-(hydroxy-.kappa.O)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-.kappa.N1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, ammonium (1:3) (PMN P-00-0365; CAS No. 1078726-28-9) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</p><p class="depth2"><em>(1)</em> The chemical substances identified as cuprate(3-), [3-[2-[5-(hydroxy-.kappa.O)-4-[2-[1-(hydroxy-.kappa.O)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-.kappa.N1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, hydrogen, compd. with 2,2'-iminobis[ethanol] (1:3:3) (PMN P-00-0364; CAS No. 1078726-27-8) and cuprate(3-), [3-[2-[5-(hydroxy-.kappa.O)-4-[2-[1-(hydroxy-.kappa.O)-6-(phenylamino)-3-sulfo-2-naphthalenyl]diazenyl-.kappa.N1]-2-methylphenyl]diazenyl]-1,5-naphthalenedisulfonato(5-)]-, ammonium (1:3) (PMN P-00-0365; CAS No. 1078726-28-9) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.</p><p class="depth2"><em>(2)</em> The significant new uses are:</p><p class="depth3"><em>(i)</em> Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80 (v)(1), (w)(1), (x)(1).</p><p class="depth3"><em>(ii)</em> [Reserved]</p><p class="depth1"><em>(b)</em> Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.</p><p class="depth2"><em>(1)</em> Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.</p><p class="depth2"><em>(2)</em> Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section.
[68 FR 15082, Mar. 28, 2003, as amended at 79 FR 34637, June 18, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
